Anti-Human Target of Rapamycin (TOR)

Anti-Human Target of Rapamycin (TOR)

Product No.: T281

[product_table name="All Top" skus="T281"]

- -
- -
Target
Target of Rapamycin
Product Type
Polyclonal Antibody
Alternate Names
mTOR, FRAP, RAFT, RAPT
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size

Data

- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human Target of Rapamycin (TOR) recognizes Human and Mouse TOR. This polyclonal antibody was purified using affinity chromatography.
Background
The mammalian Target of Rapamycin (TOR, also known as mTOR) is an evolutionarily conserved serine/threonine kinase that regulates cell growth and cell cycle through its ability to integrate signals from nutrient levels and growth factors (reviewed in 1). It was initially discovered as a kinase whose ability to stimulate T cell proliferation in response to IL-2 could be inhibited by the immunosuppressive drug rapamycin.2,3 Rapamycin inhibits TOR in other cell types resulting in reduced cell growth and reduced rates of cell cycle and cell proliferation (reviewed in 4). TOR is normally associated with the regulatory proteins RAPTOR and GβL. Its downstream targets are thought to be the ribosomal protein S6 kinases and the eukaryotic initiation factor 4E binding proteins (4EBPs). Regulation of these protein families allows TOR to control protein biosynthesis.4

Antigen Details

References & Citations

1. Shamji, AF. et al. (2003) Mol. Cell 12:271
2. Sabatini, DM. et al. (1994) Cell 78:35
3. Cardenas, ME. et al. (1995) Curr. Opin. Nephrol. Hypertens. 4:472
4. Fingar, DC. et al.(2004) Oncogene 23:3151
IHC FFPE
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.